Research by Investigator

Investigator Initiative

Allan Andersen, MD

- Risk factors for immune-related disease in individuals with substance use disorders

Aubrey Chan, MD, PhD

- Determining the role of acid sensing channnels in neuronal activity and mouse fear response
- The outcomes and operating characteristics of integrated inpatient med-psch units                                            

Eric Epping, MD, PhD

- Characterization of Schizophrenia Genetic Risk Factors from Whole Exome Sequencing
- Identification of DNA Sequence Mutations in Regions of Copy Number Variation in Schizophrenia Patients
- Creatine Safety, Tolerability, Efficacy in Huntington's Disease

Beng Choon Ho, MD

- Adolescent Cannabis Use, Complex Brain Network Connectivity & Schizophrenia Risk
- High-throughput Combined Assay of Multiplex Serum Biomarkers for Schizophrenia

Karin Hoth, PhD


Karin Hoth Lab

Cardiopulmonary Mechanisms Affecting Cognition in COPD

Doug Langbehn, MD, PhD

- Track HD and Track-On HD
- Statistical Design of Huntington's Disease Studies and the Analysis and Modeling of HD Data

Jeffrey Long, PhD 

- Functional Connectivity in Premanifest Huntington's Disease (co-investigator)
- Network of Excellence in Neuroscience Clinical Trials (NEXT)-DCC (co-investigator)
- Basal Ganglia Shape Analysis and Circuitry in Huntington's Disease (co-investigator)
- Neurobiological Predictors of Huntington's Disease (PREDICT-HD) (co-investigator)

Alison Lynch, MD, MS

- Medication for Addiction Treatment (MAT) for Opioid Use Disorder
- Service Delivery and Treatment for Substance Use Disorders
- Neuromodulation with Transcranial Magnetic Stimulation in the Treatment of Methamphetamine Use Disorder
- Emotional Experiences of Polycystic Ovary Syndrome

Jacob Michaelson, PhD 

Jacob Michaelson Laboratory
- Genetics of neurodevelopmental conditions (ASD, ID, DD)
- Gender differences in neurodevelopmental conditions
- Genetics of language ability
- Machine learning to improve the interpretation of non-coding genetic variants
- Functional and regulatory genomics in the brain

Del Miller, MD, PharmD

- ACLAIMS (A Comparison of Long-Acting Injectiable Medications for Schizophrenia)
- Phase III Study of an Adjunctive Medication for Patients with Schizophrenia with Persistent, Predominant Negative Symptoms

- Phase III Study of an Adjunctive Medication for Patients with Schizophrenia with Sub-Optimally Controlled Symptoms

Alzheimer's Research

David Moser, PhD

- Vascular Function, Cognition, and Brain MRI in Atherosclerotic Vascular Disease

Mark Niciu, MD, PhD

Mark Niciu Laboratory

- Experimental Therapeutics of Major Mood Disorders
- Co-occuring Psychiatric and Substance Use Disorders

Krystal Parker, PhD

Parker Lab

- Cerebellar contribution to cognition 
- Potential for cerebellar stimulation to rescue cognitive impairments in humans with schizophrenia

Robert Philibert, MD, PhD

- The Effects of Smoking on DNA Methylation in Primary Human Lymphocyte
- Examination of Genetic and GxE Effects in the Family and Community Health Studies
- Factors Influencing the Health Behaviors of Young African American Adults
- Using DNA Methylation to Determine Recent Alcohol Consumption Patterns
- A Transdiciplinary Center Focused on Rural African American Families

Anthony Purgianto, MD, PhD

- Interventional Psychiatry/ Neuromodulation (ECT, TMS, Ketamine, DBS, VNS treatments) for mood disorders
- Neuromodulation Task Force Consensus Recommendations for TMS in Depression
- National Network of Depression Centers

Jordan Schultz, PharmD

Schultz Lab

- AUTO-HD: Autonomic Function in Huntington's Disease Study
- TZ-PD: Terazosin for Parkington's Disease Study
- TZ-HD: Terazosin for Huntington's Disease Study
- TZ-AD: Terazosin for Alzheimer's Disease Study
- WEAR-HD: Wearable Device in Huntington's Disease Study

Hanna E. Stevens, MD, PhD

Psychiatry and Early Neurobiological Development Laboratory

Nick Trapp, MD, MD

Trapp Lab

- University of Iowa Interventional Psychiatry Service Patient Registry
- Cerebellar Stimulation and Cognitive Control
- DBS for OCD
- TMS Targeting
- Transcranial Magnetic Stimulation Pilot Study for Methamphetamine Use Disorder

Beth Troutman, PhD

Parent-Child Interaction Therapy  

Carolyn Turvey, PhD

- Combined Illness Management and Psychotherapy in Treating Depressed Elders
- My HealtheVet Project: Blue Button Feature Evaluation
- DRI Training: the Conduct of Psychosocial Care Intervention

Thomas Wassink, MD

- A Family-Genetic Study of Language in Autism

Andrea Weber, MD, MME

 - Training Expansion in Addiction Medicine and Medications for Addiction Treatment at the University of Iowa (TEAM-MAT-UI)

John Wemmie, MD, PhD

John Wemmie Laboratory
- Brain pH and Acid Sensing in Depression Related Behavior
- Modeling CO2‐Evoked Fear in Mice: Role of Acid‐Sensing Ion Channels
- Regulation of Cerebral Blood Flow by Acid-Sensing Ion Channels (ASICs)
- Anti-depressant Effects of Targeting ASIC1a in the Nucleus Accumbens

Aislinn Williams, MD, PhD

Williams Lab
- Developmental pathways involved in neuropsychiatric disease
- Voltage-gated calcium channel genes

Virginia Willour, PhD

Back to Top

- Attempted Suicide Candidate Gene Resequencing
- Suicide Epigenetics
- Genetic Risk Factor for Suicidal Behavior